Chemical Structure : LFM-A13
CAS No.: 244240-24-2
货号: PC-45399Not For Human Use, Lab Use Only.
LFM-A13 is a highly specific inhibitor of BTK with Ki of 1.4 uM, IC50 of 17.2 uM, shows no activity against EGFR, IRK, JAK1, JAK3, or HCK.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥880 | In stock | |
25 mg | ¥1380 | In stock | |
50 mg | ¥2280 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
LFM-A13 is a highly specific inhibitor of BTK with Ki of 1.4 uM, IC50 of 17.2 uM, shows no activity against EGFR, IRK, JAK1, JAK3, or HCK.
LFM-A13 enhances the sensitivity to ceramide- or vincristine-induced apoptosis in BTK+ B-lineage leukemic cells; prolongs the median survival time of VPL-treated mice.
LFM-A13 also inhibits Plk3 with IC50 of 61 uM, prevented bipolar mitotic spindle assembly in human breast cancer cells and glioblastoma cells, delays tumor progression in MMTV/neu transgenic mouse model of HER2 positive breast cancer.
分子量 | 360.0014 | |
分子式 | C11H8Br2N2O2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: ≥ 42 mg/mL |
|
Chemical Name/SMILES |
2-Butenamide, 2-cyano-N-(2,5-dibromophenyl)-3-hydroxy-,(2Z)- |
1. Mahajan S, et al. J Biol Chem. 1999 Apr 2;274(14):9587-99.
2. Uckun FM, et al. Bioorg Med Chem. 2007 Jan 15;15(2):800-14.
3. Uckun FM, et al. Clin Cancer Res. 2002 May;8(5):1224-33.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright